These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
826 related articles for article (PubMed ID: 30387329)
1. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation. McCarthy AJ; Capo-Chichi JM; Spence T; Grenier S; Stockley T; Kamel-Reid S; Serra S; Sabatini P; Chetty R J Pathol Clin Res; 2019 Apr; 5(2):115-129. PubMed ID: 30387329 [TBL] [Abstract][Full Text] [Related]
2. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma]. Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256 [No Abstract] [Full Text] [Related]
3. [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases]. Liu Y; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Zang FL; Qiu ZQ; Sun BC; Sun Y Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):369-375. PubMed ID: 33831997 [No Abstract] [Full Text] [Related]
4. [Analysis of microsatellite instability in endometroid carcinoma with deficient mismatch repair]. Zhang YH; Wu HW; Wang J; Liang ZY Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):470-475. PubMed ID: 33915653 [No Abstract] [Full Text] [Related]
5. Detection of DNA Mismatch Repair Protein Abnormalities in Sudanese Colorectal Cancer Patients Using Immunohistochemical Methods. Zakout YM; Lanza G J Gastrointest Cancer; 2019 Sep; 50(3):530-536. PubMed ID: 29850986 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma. Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ Pathology; 2010; 42(5):409-13. PubMed ID: 20632815 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Analysis of Mismatch Repair Gene Proteins in Early Gastric Cancer Based on Microsatellite Status. Sugimoto R; Endo M; Osakabe M; Toya Y; Yanagawa N; Matsumoto T; Sugai T Digestion; 2021; 102(5):691-700. PubMed ID: 33053554 [TBL] [Abstract][Full Text] [Related]
11. An exploration of gastric cancer with heterogeneous mismatch repair status. Wang X; Jiang K; Hu Y; Zhao X; Yin L; Diao X; Ma X; Xu Y; Bai Y; Zhang Y; Li Z; Sun Y Virchows Arch; 2023 Mar; 482(3):517-523. PubMed ID: 36754896 [TBL] [Abstract][Full Text] [Related]
12. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers]. Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605 [No Abstract] [Full Text] [Related]
14. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D. Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219 [TBL] [Abstract][Full Text] [Related]
15. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Shia J; Klimstra DS; Nafa K; Offit K; Guillem JG; Markowitz AJ; Gerald WL; Ellis NA Am J Surg Pathol; 2005 Jan; 29(1):96-104. PubMed ID: 15613860 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant therapy induces loss of MSH6 expression in colorectal carcinoma. Bao F; Panarelli NC; Rennert H; Sherr DL; Yantiss RK Am J Surg Pathol; 2010 Dec; 34(12):1798-804. PubMed ID: 21107085 [TBL] [Abstract][Full Text] [Related]
17. Testing for Microsatellite Instability in Colorectal Cancer - a Comparative Evaluation of Immunohistochemical and Molecular Methods. Vg DR; Nayanar SK; Gopinath V; Philip KJ; Aryadan N; Nair V; Perumal V Gulf J Oncolog; 2022 May; 1(39):70-78. PubMed ID: 35695349 [TBL] [Abstract][Full Text] [Related]
18. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759 [TBL] [Abstract][Full Text] [Related]
19. Practical guidance for mismatch repair-deficiency testing in endometrial cancer. Stelloo E; Jansen AML; Osse EM; Nout RA; Creutzberg CL; Ruano D; Church DN; Morreau H; Smit VTHBM; van Wezel T; Bosse T Ann Oncol; 2017 Jan; 28(1):96-102. PubMed ID: 27742654 [TBL] [Abstract][Full Text] [Related]
20. A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer. Wang C; Kuang W; Zeng J; Ren Y; Liu Q; Sun H; Feng M; Liang D PeerJ; 2023; 11():e15920. PubMed ID: 37663290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]